Wolverine Asset Management’s Core Scientific Inc Tranche 1 Warrants CORZW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.17M Sell
362,263
-2,354
-0.6% -$25.2K 0.03% 438
2025
Q4
$3.08M Buy
364,617
+74,026
+25% +$821K 0.02% 471
2025
Q3
$3.38M Sell
290,591
-22,250
-7% -$189K 0.03% 441
2025
Q2
$3.39M Buy
312,841
+114,129
+57% +$567K 0.03% 420
2025
Q1
$602K Buy
198,712
+23,358
+13% +$143K 0.01% 812
2024
Q4
$1.44M Buy
175,354
+67,988
+63% +$615K 0.01% 599
2024
Q3
$721K Buy
107,366
+27,283
+34% +$150K 0.01% 781
2024
Q2
$361K Buy
80,083
+60,249
+304% +$122K ﹤0.01% 903
2024
Q1
$26.4K Buy
+19,834
New +$29.4K ﹤0.01% 1184

Other funds holding CORZW

Wolverine Asset Management's CORZW Position: Q1 2026 in Review

Wolverine Asset Management reduced its Core Scientific Inc Tranche 1 Warrants (CORZW) stake by 0.65% in Q1 2026, selling an estimated $25.2K and leaving 362,263 shares worth $3.17M. The position accounts for 0.03% of the portfolio, ranked #438.

Wolverine Asset Management first reported a position in CORZW in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.39M in Q2 2025. 63 funds tracked by Wall St. Rank hold CORZW as of Q1 2026.

  • Wolverine Asset Management held 362,263 shares of Core Scientific Inc Tranche 1 Warrants worth $3.17M as of Q1 2026.
  • Wolverine Asset Management sold 2,354 Core Scientific Inc Tranche 1 Warrants shares in Q1 2026, an estimated $25.2K.
  • Core Scientific Inc Tranche 1 Warrants made up 0.03% of Wolverine Asset Management's portfolio in Q1 2026, its #438 holding.
  • Wolverine Asset Management first reported a position in Core Scientific Inc Tranche 1 Warrants in Q1 2024 and has held it in 9 quarters since.
  • Wolverine Asset Management's Core Scientific Inc Tranche 1 Warrants position peaked at $3.39M in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 1 Warrants as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.